Skip to main content

PMGC Holdings Inc.

corporate_fare Company Profile

PMGC Holdings Inc.

ELAB·NASDAQ·Industrial Applications And Services·CIK 0001840563

As of December 31, 2025, the company manages and operates a diverse portfolio of four wholly owned subsidiaries across the medical aesthetics and biopharmaceutical sectors. Northstrive Biosciences Inc. is a biopharmaceutical company that develops and acquires aesthetic medicines and therapeutic products. Its lead asset, EL-22, uses an engineered probiotic approach to address muscle preservation during weight loss treatments, including those using GLP-1 receptor agonists. PMGC Capital LLC is a multi-strategy investment firm that focuses on direct investments, strategic lending, and acquiring undervalued companies and assets across various markets. Pacific Sun Packaging, Inc. is a specialty packaging provider that offers high-precision, component-level packaging solutions for the electronics and information technology hardware industries. The company designs and supplies custom-engineered protective packaging for components such as CPUs, DIMMs, SO-DIMMs, SSDs, HDDs, and fiber-optic transceivers, serving customers in the semiconductor, data center, and networking equipment supply chains. AGA Precision Systems LLC is a specialized CNC machine shop that performs high-tolerance milling, turning, mold manufacturing, and machining of complex metals like titanium and Inconel. It serves customers in the aerospace, defense, and industrial sectors by delivering precision components. On January 16, 2025, the company completed the divestiture of assets related to its former Elevai Skincare Inc. business, which previously specialized in physician-dispensed skincare products.

PMGC Holdings Inc. (NASDAQ:ELAB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 63 items for ELAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for ELAB spans 10-Q, 8-K.

Recent high-impact activity:

  • PMGC Posts Record $2.53M Q3 Revenue, Up 785% Year-Over-Year, But Losses Persist
  • PMGC Q3 10-Q: $10.2M Nine-Month Loss, Going Concern Doubt, $7.3M ELOC Convertible Debt
  • PMGC Puts $1.845M Into Nuclea Canada Debentures Tied to Moltex Deal and Its Own SPAC
  • PMGC Completes $100M SPAC IPO, Launches NorthStrive Acquisition Corp. I
  • PMGC Secures Five-Year Royalty Stream from Elevai Skincare Sale

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$590.08K
Net Income
-$7.75M
Op. Cash Flow
-$5.93M
Free Cash Flow
-$6.38M
Gross Profit
$185.31K
Cash & Equivalents
$5.4M
Debt / Equity
0.00×
Net Margin
-13.13×
Shares Outstanding
80.7K sh
Source: 10-K · filed 2026-03-30 · accession 0001213900-26-035937

Short Interest & Short Volume

2.61 days to cover

FINRA reported short interest of 18,653 shares in ELAB as of the October 30, 2026 settlement, a 0.7% increase from the prior period — about 2.6 days to cover at its recent average daily volume. On November 20, 2026, 16.6% of ELAB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)18,653 shares as of October 30, 2026
Change vs prior period▲ 0.7%
Days to cover2.61 at avg daily volume of 7,155
Daily short volume (FINRA facilities)16.6% of 44,826 shares on November 20, 2026
5-day average short volume41.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with E →
$1.17 +2.63% today
52-week range · as of 2026-11-13 $1.17 – $1432.8
Market cap
$1.33M
Volume
68.5K (0.1× avg)
3-mo avg 534.8K
Live data · 2026-11-21 11:05 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ELAB - Latest Insights

ELAB
Nov 16, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $1.17 info
Change: -$0.4607 (-28%) info
Market Cap: $1.333M info
ELAB
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $1.17 info
Change: -$0.410 (-26%) info
Market Cap: $1.333M info
ELAB
Nov 02, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $1.17 info
Change: -$0.950 (-45%) info
Market Cap: $1.333M info
ELAB
Oct 01, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.62
Real-time Price: $1.17 info
Change: -$2.45 (-68%) info
Market Cap: $1.333M info
ELAB
Sep 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $1.17 info
Change: -$3.53 (-75%) info
Market Cap: $1.333M info
ELAB
Sep 02, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $1.17 info
Change: -$4.03 (-78%) info
Market Cap: $1.333M info
ELAB
Sep 01, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.23
Real-time Price: $1.17 info
Change: -$4.06 (-78%) info
Market Cap: $1.333M info
ELAB
Aug 27, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.80
Real-time Price: $1.17 info
Change: -$4.63 (-80%) info
Market Cap: $1.333M info
ELAB
Aug 26, 2026, 8:17 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.24
Real-time Price: $1.17 info
Change: -$4.07 (-78%) info
Market Cap: $1.333M info
ELAB
Aug 19, 2026, 11:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7868
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Aug 14, 2026, 9:55 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Aug 14, 2026, 9:31 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9327
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jul 29, 2026, 3:54 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.8775
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jul 13, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jul 07, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jul 06, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jul 01, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jul 01, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jun 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
ELAB
Jun 08, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $1.17 info
Change: Reverse Stock Split info
Market Cap: $1.333M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets